Nykode Therapeutics (NYKD)

Last close As at 28/03/2025

NOK2.29

0.19 (9.16%)

Market capitalisation

NOK685m

Nykode Therapeutics is an Oslo-based clinical-stage biopharmaceutical platform company dedicated to the discovery of novel immunotherapies. Nykode’s vision is to become a leading immunotherapy company, developing therapeutics across a range of areas with high unmet medical need, such as cancers and autoimmune diseases.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free